Peritoneal Fluid Lactate Dehydrogenase in Ovarian Cancer

By Schneider D.   Halperin R.   Langer R.   Bukovsky I.   Herman A.  

Gynecologic Oncology, Vol. 66, Iss. 3, 1997-09 ,pp. : 399-404

Elsevier

Access to resources Recommend Favorite

Weekly Low-Dose Carboplatin and Paclitaxel in the Treatment of Recurrent Ovarian and Peritoneal Cancer

By Havrilesky L.J.   Alvarez A.A.   Sayer R.A.   Lancaster J.M.   Soper J.T.   Berchuck A.   Clarke-Pearson D.L.   Rodriguez G.C.   Carney M.E.  

Gynecologic Oncology, Vol. 88, Iss. 1, 2003-01 ,pp. : 51-57

Academic Press

Access to resources Recommend Favorite

Hereditary Ovarian Cancer: Molecular Genetics and Clinical Implications

By Boyd J.   Rubin S.C.  

Gynecologic Oncology, Vol. 64, Iss. 2, 1997-02 ,pp. : 196-206

Elsevier

Access to resources Recommend Favorite

The Clinical Utility of Liposomal Doxorubicin in Recurrent Ovarian Cancer

By Campos S.M.   Penson R.T.   Mays A.R.   Berkowitz R.S.   Fuller A.F.   Goodman A.   Matulonis U.A.   Muzikansky A.   Seiden M.V.  

Gynecologic Oncology, Vol. 81, Iss. 2, 2001-05 ,pp. : 206-212

Elsevier

Access to resources Recommend Favorite

Clinical Picture of Women with Early Stage Ovarian Cancer

By Eltabbakh G.H.   Yadev P.R.   Morgan A.  

Gynecologic Oncology, Vol. 75, Iss. 3, 1999-12 ,pp. : 476-479

Elsevier

Access to resources Recommend Favorite